Ellen Stokvis
About
Ellen Stokvis is a scholar working on Molecular Biology, Spectroscopy and Oncology.
According to data from OpenAlex, Ellen Stokvis has authored 21 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Spectroscopy and 8 papers in Oncology. Recurrent topics in Ellen Stokvis's work include Mass Spectrometry Techniques and Applications (9 papers), Analytical Chemistry and Chromatography (5 papers) and Cancer Treatment and Pharmacology (5 papers). Ellen Stokvis is often cited by papers focused on Mass Spectrometry Techniques and Applications (9 papers), Analytical Chemistry and Chromatography (5 papers) and Cancer Treatment and Pharmacology (5 papers). Ellen Stokvis collaborates with scholars based in Netherlands, Spain and United States. Ellen Stokvis's co-authors include Jos H. Beijnen, Hilde Rosing, Jan H.M. Schellens, José Jimeno, Albert J. R. Heck, Cees Versluis, Luis López Lázaro, Jeany M. Rademaker-Lakhai, Liia D. Vainchtein and Simon Horenblas and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Molecular Plant-Microbe Interactions.
In The Last Decade
Ellen Stokvis
21 papers receiving 894 citations
Peers
Ellen Stokvis
Cesar A. Lau‐Cam United States
Patrick J. Rudewicz United States
Sophie Martel Switzerland
N. J. Haskins United Kingdom
Timo Mauriala Finland
Sérgio Luiz Dalmora Brazil
Milan Nobilis Czechia
G.G. Skellern United Kingdom
Nicola Hughes United States
Christopher Bevan United States
Citations per year, relative to Ellen Stokvis Ellen Stokvis (= 1×)
peers
Cesar A. Lau‐Cam
Countries citing papers authored by Ellen Stokvis
Since
Specialization
Citations
This map shows the geographic impact of Ellen Stokvis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Stokvis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Stokvis more than expected).
Fields of papers citing papers by Ellen Stokvis
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ellen Stokvis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Stokvis. The network helps show where Ellen Stokvis may publish in the future.
Co-authorship network of co-authors of Ellen Stokvis
This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Stokvis. A scholar is included among the top collaborators of Ellen Stokvis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Stokvis. Ellen Stokvis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Stokvis, Ellen, Hilde Rosing, & Jos H. Beijnen. (2005). Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not?. Rapid Communications in Mass Spectrometry. 19(3). 401–407.
2.
Vainchtein, Liia D., Bas Thijssen, Ellen Stokvis, et al.. (2005). A simple and sensitive assay for the quantitative analysis of paclitaxel and metabolites in human plasma using liquid chromatography/tandem mass spectrometry. Biomedical Chromatography. 20(1). 139–148.
3.
Rademaker-Lakhai, Jeany M., Simon Horenblas, W. Meinhardt, et al.. (2005). Phase I Clinical and Pharmacokinetic Study of Kahalalide F in Patients with Advanced Androgen Refractory Prostate Cancer. Clinical Cancer Research. 11(5). 1854–1862.
4.
Stokvis, Ellen, Hilde Rosing, & Jos H. Beijnen. (2004). Liquid chromatography‐mass spectrometry for the quantitative bioanalysis of anticancer drugs. Mass Spectrometry Reviews. 24(6). 887–917.
5.
Stokvis, Ellen, Hilde Rosing, Roger C. Causon, Jan H.M. Schellens, & Jos H. Beijnen. (2004). Quantitative analysis of the P‐glycoprotein inhibitor Elacridar (GF120918) in human and dog plasma using liquid chromatography with tandem mass spectrometric detection. Journal of Mass Spectrometry. 39(10). 1122–1130.
6.
Stokvis, Ellen, Hilde Rosing, Mirjam Crul, et al.. (2004). Quantitative analysis of the novel anticancer drug ABT‐518, a matrix metalloproteinase inhibitor, plus the screening of six metabolites in human plasma using high‐performance liquid chromatography coupled with electrospray tandem mass spectrometry. Journal of Mass Spectrometry. 39(3). 277–288.
7.
Stokvis, Ellen, Mariët Ouwehand, Matthijs M. Tibben, et al.. (2004). Quantitative analysis of D‐24851, a novel anticancer agent, in human plasma and urine by liquid chromatography coupled with tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 18(13). 1465–1471.
8.
Stokvis, Ellen, et al.. (2004). Simple and sensitive liquid chromatographic quantitative analysis of the novel marine anticancer drug Yondelis™ (ET‐743, trabectedin) in human plasma using column switching and tandem mass spectrometric detection. Journal of Mass Spectrometry. 39(4). 431–436.
9.
Stokvis, Ellen, Mariët Ouwehand, E. Marleen Kemper, et al.. (2004). A simple and sensitive assay for the quantitative analysis of paclitaxel in human and mouse plasma and brain tumor tissue using coupled liquid chromatography and tandem mass spectrometry. Journal of Mass Spectrometry. 39(12). 1506–1512.
10.
Stokvis, Ellen, et al.. (2004). Switching from an analogous to a stable isotopically labeled internal standard for the LC‐MS/MS quantitation of the novel anticancer drug Kahalalide F significantly improves assay performance. Biomedical Chromatography. 18(6). 400–402.
11.
Stokvis, Ellen, Hilde Rosing, Luis López Lázaro, Jan H.M. Schellens, & Jos H. Beijnen. (2004). A more sensitive MS detector does not obviously lead to a more sensitive assay: experiences with ES‐285. Biomedical Chromatography. 18(6). 403–407.
12.
Beijnen, J. H., Jeany M. Rademaker-Lakhai, Simon Horenblas, et al.. (2004). Phase I and pharmacokinetic study of Kahalalide F in patients with advanced androgen refractory prostate cancer. Journal of Clinical Oncology. 22(14_suppl). 2076–2076.
13.
Stokvis, Ellen, Hilde Rosing, José Luis Aceña, et al.. (2003). Quantitative analysis of ES‐285, an investigational marine anticancer drug, in human, mouse, rat, and dog plasma using coupled liquid chromatography and tandem mass spectrometry. Journal of Mass Spectrometry. 38(5). 548–554.
14.
Stokvis, Ellen, Hilde Rosing, Ignacio Rodríguez‐García, et al.. (2002). Quantitative analysis of the novel depsipeptide anticancer drug Kahalalide F in human plasma by high‐performance liquid chromatography under basic conditions coupled to electrospray ionization tandem mass spectrometry. Journal of Mass Spectrometry. 37(9). 992–1000.
15.
Crul, Mirjam, Laurens V. Beerepoot, Ellen Stokvis, et al.. (2002). Clinical pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase inhibitor ABT-518. Cancer Chemotherapy and Pharmacology. 50(6). 473–478.
16.
Stokvis, Ellen, Hilde Rosing, José Jimeno, et al.. (2002). Bioanalysis of the novel peptide anticancer drug kahalalide F in human plasma by h.p.l.c. under basic conditions coupled with positive turbo‐ionspray tandem mass spectrometry. British Journal of Clinical Pharmacology. 53(5).
17.
Sparidans, Rolf W., Ellen Stokvis, José Jimeno, et al.. (2001). Chemical and enzymatic stability of a cyclic depsipeptide, the novel, marine-derived, anti-cancer agent kahalalide F. Anti-Cancer Drugs. 12(7). 575–582.
18.
Nuijen, Bastiaan, Marjan Bouma, Hilde Rosing, et al.. (2001). DEVELOPMENT OF AN HPLC METHOD WITH UV DETECTION FOR THE PHARMACEUTICAL QUALITY CONTROL OF THE NOVEL MARINE ANTICANCER AGENT KAHALALIDE F. Journal of Liquid Chromatography & Related Technologies. 24(20). 3141–3155.
19.
Stokvis, Ellen, Susan L. Clugston, John F. Honek, & Albert J. R. Heck. (2000). Characterization of Glyoxalase I (E. coli)—Inhibitor Interactions by Electrospray Time-of-Flight Mass Spectrometry and Enzyme Kinetic Analysis. Journal of Protein Chemistry. 19(5). 389–397.
20.
Olsthoorn, Maurien M. A., Ellen Stokvis, Johan Haverkamp, Herman P. Spaink, & Jane Thomas‐Oates. (2000). Growth Temperature Regulation of Host-Specific Modifications of Rhizobial Lipo-Chitin Oligosaccharides: The Function of nodX Is Temperature Regulated. Molecular Plant-Microbe Interactions. 13(8). 808–820.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Cesar A. Lau‐Cam Breakdown of academic impact, for papers by Patrick J. Rudewicz Breakdown of academic impact, for papers by Sophie Martel Breakdown of academic impact, for papers by N. J. Haskins Breakdown of academic impact, for papers by Timo Mauriala Breakdown of academic impact, for papers by Sérgio Luiz Dalmora Breakdown of academic impact, for papers by Milan Nobilis Breakdown of academic impact, for papers by G.G. Skellern Breakdown of academic impact, for papers by Nicola Hughes Breakdown of academic impact, for papers by Christopher Bevan